The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Protease Inhibitor Use and the Incidence of Diabetes Mellitus in a Large Cohort of HIV-Infected Women
Abstract
OBJECTIVE: To assess the association between protease inhibitor (PI) use and the incidence of diabetes mellitus (DM) among participants in the Women's Interagency HIV Study. DESIGN: Prospective multicenter cohort study. The diagnosis of DM was based on self-report at semiannual interviews conducted from 1994 to 1998. SETTING: Six inner-city clinical sites in the United States (Brooklyn, NY; Bronx, NY; Washington, DC; Chicago, IL; San Francisco, CA; and Los Angeles, CA). PARTICIPANTS: A total of 1785 nonpregnant women who had no history of prior DM. The women made up four groups: 1) PI users (n = 609, person-years [PY] at risk = 707); 2) reverse transcriptase inhibitor (RTI)-only users (n = 932, PY = 1486); 3) HIV-infected women reporting no antiretroviral therapy (ART) ever (n = 816, PY = 1480); and 4) HIV-uninfected women (n = 350, PY = 905). MAIN OUTCOMES: Incidence of DM and median body mass index (BMI) from 1995 to 1998 were compared among the four groups. RESULTS: Sixty-nine incident cases of DM occurred among 1785 women (1.5 cases per 100 PY; 95% CI: 1.2-1.9). The incidence of DM among PI users was 2.8 cases per 100 PY (2.8%) versus 1.2% among both RTI users and women on no ART (95% CI: 1.6-4.1 [PI]; 0.7-1.8 [RTI and no ART]; P = 0.01 for comparison of the PI group with the RTI group) and 1.4% among HIV-uninfected women (95% CI: 0.7-2.2, P = 0.06 for comparison with PI group). Weight gain was not associated with either PI or RTI use. Multivariate models identified PI use (hazard ratio [HR] = 2.90 [95% CI: 1.50-5.60]; P = 0.002), age (HR = 1.75 per 10 years [95% CI: 1.31-2.34]; P = 0.0002) and BMI as independent risk factors for DM. CONCLUSIONS: PI use was associated with a threefold increase in the risk of reporting incident DM. Routine screening for diabetes, particularly among older and heavier patients using PI therapy, is advisable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Walli, R., Herfort, O., Michl, G. M., Demant, T., Jäger, H., Dieterle, C., Bogner, J. R., Landgraf, R., & Goebel, F. D. (1998) · AIDS · doi:10.1097/00002030-199815000-00001 · Cited by 519
Cited by
Brown, T. T. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.10.1179 · Cited by 851
The Women's Interagency HIV Study: an Observational Cohort Brings Clinical Sciences to the Bench
Bacon, M. C., von Wyl, V., Alden, C., Sharp, G., Robison, E., Hessol, N., Gange, S., Barranday, Y., Holman, S., Weber, K., et al. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.9.1013-1019.2005 · Cited by 520
Self-citationGreater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy
Bourgi, K., Rebeiro, P. F., Turner, M., Castilho, J. L., Hulgan, T., Raffanti, S. P., Koethe, J. R., & Sterling, T. R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz407 · Cited by 327
Marais, B. J., Lönnroth, K., Lawn, S. D., Migliori, G. B., Mwaba, P., Glaziou, P., Bates, M., Colagiuri, R., Zijenah, L., Swaminathan, S., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70015-x · Cited by 314
Ledergerber, B., Furrer, H., Rickenbach, M., Lehmann, R., Elzi, L., Hirschel, B., Cavassini, M., Bernasconi, E., Schmid, P., Egger, M., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/518619 · Cited by 261
Metadata
- Authors
- Justman, J. E., Benning, L., Danoff, A., Minkoff, H., Levine, A., Greenblatt, R. M., Weber, K., Piessens, E., Robison, E., & Anastos, K.
- Venue
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2003-03
- Volume
- 32
- Issue
- 3
- Pages
- 298-302
- ISSN
- 1525-4135 (ISSN-L)
- OpenAlex
- W2049170123
- Cited by
- 213
- References
- 1
- FWCI
- 16.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Protease Inhibitor Use and the Incidence of Diabetes Mellitus in a Large Cohort of HIV-Infected Women. https://app.cochat.ai/papers/10.1097/00126334-200303010-00009
- The paper
- Justman, J. E., Benning, L., Danoff, A., Minkoff, H., Levine, A., Greenblatt, R. M., Weber, K., Piessens, E., Robison, E., & Anastos, K. (2003). Protease Inhibitor Use and the Incidence of Diabetes Mellitus in a Large Cohort of HIV-Infected Women. JAIDS Journal of Acquired Immune Deficiency Syndromes. https://doi.org/10.1097/00126334-200303010-00009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.